Christopher Freeman
Corporate Officer/Principal en GUARDANT HEALTH, INC. .
Fortuna: 329 482 $ al 31/03/2024
Perfil
Christopher Freeman is currently the Director at Dream Foundation and the Chief Commercial Officer at Guardant Health, Inc. He previously worked as the Vice President-HIV Business Unit at Gilead Sciences, Inc. from 2020 to 2021.
Freeman received his undergraduate degree from the US Military Academy.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GUARDANT HEALTH, INC.
0.01% | 01/04/2024 | 15 971 ( 0.01% ) | 329 482 $ | 31/03/2024 |
Cargos activos de Christopher Freeman
| Empresas | Cargo | Inicio |
|---|---|---|
| GUARDANT HEALTH, INC. | Corporate Officer/Principal | 01/06/2021 |
| Dream Foundation | Director/Board Member | - |
Antiguos cargos conocidos de Christopher Freeman.
| Empresas | Cargo | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/06/2021 |
Formación de Christopher Freeman.
| US Military Academy | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| GUARDANT HEALTH, INC. | Health Services |
| Empresas privadas | 1 |
|---|---|
| Dream Foundation |
- Bolsa de valores
- Insiders
- Christopher Freeman
